S
Screenpoint Medical
Smart AI for early breast cancer detection
About Screenpoint Medical
ScreenPoint Medical specializes in developing advanced AI-driven image analysis technology designed to automate the reading of mammograms and digital breast tomosynthesis (DBT) examinations. The company's flagship product, Transpara, is a decision support solution that aids radiologists and healthcare providers in early breast cancer detection and diagnosis. ScreenPoint Medical operates in the healthcare and medical imaging market, targeting radiologists, diagnostic centers, and healthcare providers. The business model is based on selling and licensing its AI software to medical institutions, generating revenue through software sales, subscriptions, and strategic partnerships. The company leverages Big Data, Deep Learning, and Artificial Intelligence to enhance the accuracy and efficiency of breast cancer screening, aiming to improve patient outcomes and reduce radiologist workload.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2014
- Headquarters
- Nijmegen, Netherlands
- Employees
- 85
- Open positions
- None listed
- Dealroom signal
- 87.5/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Image Recognition, Oncology, Screening, Radiology, Medical Imaging
- Technology
- Artificial Intelligence, Deep Tech, Machine Learning, Deep Learning, Nanotech
- Business model
- SaaS
- Client focus
- b2b
- Investment activity
- 1 company, latest Jan 2025
- Capital deployed
- —
- Preferred round
- ACQUISITION
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| GRANT✓Other financing | Apr 2026 | $2M | — | Undisclosed | ↗ |
| LATE VC✓Equity / VC | Apr 2026 | $14M | $140M | Siemens Healthineers · Insight Partners | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Screenpoint Medical is 2.4K monthly website visits, up 9.1% over the last three months. Screenpoint Medical's team grew 18.1% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Siemens
Series B and later4 investors entered at this stage
Insight Partners
University Radiology Group
Oost NL - Eastern Netherlands Regional Development Agency
Siemens Healthineers
Other known investors2 additional known investors
Radboud University- MBMichael Brady
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Screenpoint Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Screenpoint Medical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







